Search research articles
Contact Us
Filters
Showing results (521-530 of 662) with videos related to
Page
of 67
Sort By:
British Journal of Haematology
|
June 1, 2021
Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto-oncogene, receptor tyrosine kinase (KIT) D816V mutations
Nicole Naumann, Johannes Lübke, William Shomali, et al.
Nature Communications
|
May 20, 2018
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity
Anna Skucha, Jessica Ebner, Johannes Schmöllerl, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 19, 2020
Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic Mastocytosis
Juliana Schwaab, Nicole Cabral do O Hartmann, Nicole Naumann, et al.
Journal of Immunological Methods
|
May 2, 2021
Culturing cells with mast cell phenotype and function: Comparison of peripheral blood and bone marrow as a source
Jessy Elst, Didier G Ebo, Margaretha A Faber, et al.
Cell Reports
|
March 2, 2017
BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1
Simon J Hogg, Stephin J Vervoort, Sumit Deswal, et al.
Blood
|
August 21, 2013
Comprehensive mutational profiling in advanced systemic mastocytosis
Juliana Schwaab, Susanne Schnittger, Karl Sotlar, et al.
Blood
|
August 11, 2020
Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis
Georg Greiner, Bettina Sprinzl, Aleksandra Górska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 27, 2015
Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML
Irina Sadovnik, Andrea Hoelbl-Kovacic, Harald Herrmann, et al.
Wiener Klinische Wochenschrift
|
July 15, 2018
Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectives
Peter Valent, Emir Hadzijusufovic, Thomas Grunt, et al.
The Journal of Allergy and Clinical Immunology
|
June 22, 2018
Mast cell activation syndrome: Importance of consensus criteria and call for research
Peter Valent, Cem Akin, Patrizia Bonadonna, et al.
Page
of 67
Search research articles
Search
Showing results (521-530 of 662) with videos related to
Sort By:
Page
of 67
British Journal of Haematology
|
June 1, 2021
Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto-oncogene, receptor tyrosine kinase (KIT) D816V mutations
Nicole Naumann, Johannes Lübke, William Shomali, et al.
Nature Communications
|
May 20, 2018
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity
Anna Skucha, Jessica Ebner, Johannes Schmöllerl, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 19, 2020
Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic Mastocytosis
Juliana Schwaab, Nicole Cabral do O Hartmann, Nicole Naumann, et al.
Journal of Immunological Methods
|
May 2, 2021
Culturing cells with mast cell phenotype and function: Comparison of peripheral blood and bone marrow as a source
Jessy Elst, Didier G Ebo, Margaretha A Faber, et al.
Cell Reports
|
March 2, 2017
BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1
Simon J Hogg, Stephin J Vervoort, Sumit Deswal, et al.
Blood
|
August 21, 2013
Comprehensive mutational profiling in advanced systemic mastocytosis
Juliana Schwaab, Susanne Schnittger, Karl Sotlar, et al.
Blood
|
August 11, 2020
Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis
Georg Greiner, Bettina Sprinzl, Aleksandra Górska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 27, 2015
Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML
Irina Sadovnik, Andrea Hoelbl-Kovacic, Harald Herrmann, et al.
Wiener Klinische Wochenschrift
|
July 15, 2018
Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectives
Peter Valent, Emir Hadzijusufovic, Thomas Grunt, et al.
The Journal of Allergy and Clinical Immunology
|
June 22, 2018
Mast cell activation syndrome: Importance of consensus criteria and call for research
Peter Valent, Cem Akin, Patrizia Bonadonna, et al.
Page
of 67